CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Sweden

  • ID: 4483508
  • Report
  • Region: Sweden
  • 133 pages
  • GlobalData
1 of 3
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Sweden

Summary

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Sweden. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Sweden. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis the team of industry experts.

Sweden is one of the largest healthcare market, with a strong focus on pharma R&D. It spends approximately 11% of it’s GDP on healthcare. The pharmaceutical market increased from SEK36.2 billion ($4.76 billion) in 2009 to SEK42.6 billion ($4.98 billion) in 2016, at a CAGR of 2.4% in terms of Swedish Krona and 0.7% in terms of US dollars .It is expected to reach SEK 47.9 billion ($5.15 billion) in 2021. The Swedish medical device market was valued at $1.96 billion in 2009, which increased to $2.60 billion in 2016.The main segments in 2016 were in vitro diagnostics, ophthalmic devices, cardiovascular devices, healthcare IT and orthopedic devices. Introduction of new medicines for the treatment of Hepatitis C and reduced savings associated with patent expirations are the contributors to pharmaceutical market growth.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Sweden, and includes:
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Orifarm, AstraZeneca and Orexo) and profiles and SWOT analyses of the major players in the medical device market (Roche Diagnostics, Essilor, Medtronic, DePuy Synthes and GE Healthcare)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Sweden
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Sweden
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Swedish healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to:
  • Develop business strategies by understanding the trends shaping and driving the Swedish healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Swedish healthcare market.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Sweden, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
Table 2: Medical Device Market, Sweden, Revenue by Segment
Table 3: IVD Devices Market, Sweden, Revenue and Market Share of Major Players
Table 4: Ophthalmic Devices Market, Sweden, Revenue and Market Share of Major Players
Table 5: Cardiovascular Devices Market, Sweden, Revenue and Market Share of Major Players
Table 6: Healthcare IT Market, Sweden, Revenue and Market Share of Major Players
Table 7: Orthopedic Devices Market, Sweden, Revenue and Market Share of Major Players
Table 8: Benefits Associated with SSIA, Sweden
Table 9: Pricing of Medicines at Different Levels, Sweden
Table 10: Application Type and Fees, 2017, Sweden
Table 11: Annual Fees, 2017, Sweden
Table 12: Patent Fees, 2017, Sweden
Table 13: Trademark Fees, 2017, Sweden
Table 14: Advertising Regulation, 2017, Sweden
Table 15: Advertising of pharmaceutical products through other mass media, 2017, Sweden
Table 16: Label of a pharmaceutical product, Sweden, 2017
Table 17: Trade Associations, Sweden
Table 18:Trade Fairs, Sweden

List of Figures
Figure 1: Pharmaceutical Market, Sweden, Revenue, 2009-2016
Figure 2: Medical Device Market, Sweden, Revenue, 2009-2016
Figure 3: Pharmaceutical Market Share (Segments), Sales, 2015
Figure 4: Number of Deals (2016-2017)
Figure 5: 2016-17 Deal Overview By Region
Figure 6: Country Profile, Sweden, 2017
Figure 7: Pharmaceutical Market, Sweden, Revenue, 2009-2016
Figure 8: Pharmaceutical Market, Sweden, Revenue Forecast, 2017-2021
Figure 9: Pharmaceutical Market, Sweden, Pharmaceutical Exports
Figure 10: Pharmaceutical Market, Sweden, Top Export Partners
Figure 11: Pharmaceutical Market, Sweden, Pharmaceutical Imports
Figure 12: Pharmaceutical Market, Sweden, Top Import Partners
Figure 13: Pharmaceutical Market, Sweden, Supply Channels
Figure 14: Pharmaceutical Market, Sweden, Sales of Patented Drug Products by Major Therapeutic Class, 2016
Figure 15: Pharmaceutical Market, Sweden, Major Players
Figure 16: Medical Device Market, Sweden, Revenue
Figure 17: Medical Device Market, Sweden, Revenue Forecast
Figure 18: Medical Device Market, Sweden, Revenue by Segment
Figure 19: In vitro Diagnostics Market, Sweden, Revenue
Figure 20: In vitro Diagnostics Market, Sweden, Market Share of Major Players
Figure 21: Ophthalmic Devices Market, Sweden, Revenue
Figure 22: Ophthalmic Devices Market, Sweden, Market Share of Major Players
Figure 23: Cardiovascular Devices Market, Sweden, Revenue
Figure 24: Cardiovascular Devices Market, Sweden, Market Share of Major Players
Figure 25: Healthcare IT Market, Sweden, Revenue
Figure 26: Healthcare IT Market, Sweden, Market Share of Major Players
Figure 27: Orthopedic Devices Market, Sweden, Revenue
Figure 28: Orthopedic Devices Market, Sweden, Market Share of Major Players
Figure 29: Diagnostic Market, Sweden, Revenue, 2009-2016
Figure 30: Diagnostic Market, Sweden, Revenue Forecast, 2017-2021
Figure 31: Medical Device Market, Sweden, Revenue of Major Players
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Sweden, 2016-2017
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Sweden, 2016-2017
Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Sweden, 2016-2017
Figure 35: Top Five Therapy Area by Deal value, Pharmaceutical Market, Sweden, 2016-2017
Figure 36: Top Five Therapy Area by Deal number, Pharmaceutical Market, Sweden, 2016-2017
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Sweden, 2016-2017 (by value and by number)
Figure 38: Venture Financing Deals by Therapy area, Pharmaceutical Market, Sweden, 2016-2017 (by value and by number)
Figure 39: Medical Device Market Deals, Sweden, 2016 - 2017 (By deal value, $ m)
Figure 40: Medical Device Market Deals, Sweden, 2016 - 2017 (By deal Count)
Figure 41: Medical Device Market deals share (by deal count), Sweden, 2016 - 2017
Figure 42: Medical Device Market deals share (by deal value), Sweden, 2016 - 2017
Figure 43: Top 5 therapy area by deal value, Medical Device, Sweden, 2016-2017
Figure 44: Top 5 therapy area by deal number, Medical Device, Sweden, 2016- 2017
Figure 45: M&A deals by therapy area, Medical Device, Sweden, 2016-2017 (By value and by number)
Figure 46: Venture Financing deals by therapy area, Medical Device, Sweden, 2016-2017 (By value and by number)
Figure 47: Private Equity deals by therapy area, Medical Device Sweden, 2016- 2017 (By value and by number)
Figure 48: Healthcare System, Sweden
Figure 49: Drug Funding and Reimbursement Approval Process, Sweden
Figure 50: Financial Flow, Sweden
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health)
Figure 52: Pharmaceutical and Consumer Price Index
Figure 53: Medical Products Agency, Organization Chart, Sweden
Figure 54: New Drug Approval Process, Sweden
Figure 55: Centralized Procedure, 2017, Sweden
Figure 56: Decentralized Procedure, 2017, Sweden
Figure 57: Mutual Recognition Procedure, 2017, Sweden
Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017
Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017
Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017
Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017
Figure 62: European Patent Approval Process, EU, 2017
Figure 63: Unitary Patent Approval Process, EU, 2017
Figure 64: Clinical Trial Process, Sweden, 2017
Figure 65: Number of Hospitals, Sweden, 2009-2016
Figure 66: Hospital Beds (per 1,000 population), Sweden
Figure 67: Acute Care Hospital Beds (per 1,000 population), Sweden
Figure 68: Psychiatric Hospital Beds (per 1,000 population), Sweden
Figure 69: Life Expectancy, 2009-2015, Sweden
Figure 70: Immunization Rate (%), 2009-2016, Sweden
Figure 71: PM2.5 (µg per m3), Sweden, 2009-2015
Figure 72: CO2 Emissions (million tons), Sweden, 2009-2015
Figure 73: Physicians (per 1,000 population), Sweden, 2009-2015
Figure 74: Nurses (per 1,000 population), Sweden, 2009-2015
Figure 75: Dentists (per 1,000 population), Sweden, 2009-2015
Figure 76: Pharmacists (per 1,000 population), Sweden, 2009-2015
Figure 77: Major Causes of Mortality (per 100,000 population), Sweden, 2015
Figure 78: Major Causes of Male Mortality, Sweden, 2015
Figure 79: Major Causes of Female Mortality, Sweden, 2015
Figure 80: Disability-Adjusted Life Years by Major Disease (‘000), Sweden, 2015
Figure 81: Healthcare Expenditure as Percentage of GDP (%), Sweden, 2009-2016
Figure 82: Public-Private Share (%), Sweden, 2009-2015
Figure 83: Major Components of Healthcare Spending (%), Sweden, 2016
Figure 84: Opportunities & Challenges, Sweden
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll